Eupraxia Pharmaceuticals, Inc. · TSX:EPRX
JAMES E. BESSER reported a 10.90% stake in Eupraxia Pharmaceuticals, Inc. (Schedule 13G)
Event Dec 31, 2024 · Filed Nov 13, 2025
JAMES E. BESSER reported a 10.90% stake in Eupraxia Pharmaceuticals, Inc., 5,839,557 shares, as a passive investor on Dec 31, 2024. Filed Nov 13, 2025 (Schedule 13G).
- Stake
- 10.90%
- Shares
- 5,839,557
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MANCHESTER MANAGEMENT COMPANY, LLC | 10.40% | 5,562,971 |
| MANCHESTER MANAGEMENT PR, LLC | 10.40% | 5,562,971 |
| MANCHESTER EXPLORER, L.P. | 10.00% | 5,337,117 |
| JAMES E. BESSER | 10.90% | 5,839,557 |
| MORGAN C. FRANK | 10.60% | 5,644,423 |
Source
Related
- Eupraxia Pharmaceuticals, Inc.
- James E. Besser
- Eupraxia Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · James E. Besser · Aug 13, 2026
- Schedule 13G/A · James E. Besser · May 12, 2026
- Schedule 13G/A · James E. Besser · Feb 17, 2026
- Schedule 13D/A · Joseph S. Freedman · Mar 16, 2026
- Schedule 13G/A · Robert Disbrow · Nov 14, 2025
- Schedule 13G · Beutel, Goodman & Co Ltd. · Nov 14, 2025
- Schedule 13D/A · Joseph S. Freedman · Sep 26, 2025